Fluid and electrolyte therapy and chronic lung disease

Current Opinion in Pediatrics

Volumn 16, Issue 2, 2004, Pages 152-156

  Lorenz, John M ^a,b  

^a Columbia University ^*  (United States)

^b Children's Hosp of NY Presbyterian   (United States)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Colloid; Fluid intake; Prematurity; Sodium intake; Water intake

Indexed keywords

ELECTROLYTE; FRESH FROZEN PLASMA; OXYGEN; SODIUM; WATER;

ARTIFICIAL VENTILATION; BODY WATER; CHRONIC LUNG DISEASE; CLINICAL TRIAL; COLLOID; CONTROLLED CLINICAL TRIAL; CORRELATION ANALYSIS; EXTRACELLULAR SPACE; FLUID BALANCE; FLUID INTAKE; FLUID THERAPY; GESTATIONAL AGE; HUMAN; META ANALYSIS; MORBIDITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PATHOGENESIS; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; RISK REDUCTION; SODIUM BALANCE; SODIUM INTAKE; URINE VOLUME; VERY LOW BIRTH WEIGHT;

CHRONIC DISEASE; HUMANS; INFANT, NEWBORN; LUNG DISEASES; RANDOMIZED CONTROLLED TRIALS; WATER-ELECTROLYTE BALANCE;

EID: 1642390160     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200404000-00006     Document Type: Review

References (26)

1. Brown ER, Stark A, Sosenko I, et al.: Bronchopulmonary dysplasia: possible relationship to pulmonary edema. J Pediatr 1978, 92:982-984.
2. Sosenko IRS, Frank L: Nutritional influences on lung development and protection against chronic lung disease. Semin Perinatol 1991, 15:462-468.
3. Palta M, Gabbert D, Weinstein M, et al.: Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. J Pediatr 1991, 119:285-292.
4. Rojas MA, Gonzalex A, Bancalari I, et al.: Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995, 126:605-610.
5. Jobe AH: Too many unvalidated new therapies to prevent chronic ling disease in preterm infants. J Pediatr 1998, 132:200-202.
6. Marshall DD, Kotelchuck M, Young TE, et al. and the North Carolina Neonatologists Association: Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. Pediatrics 1999, 104:1345-1350.
7. Bancalari E: Epidemiology and risk factors for the "new" bronchopulmonary dysplasia. Neoreviews 2000, 1:e2-e5.
8. Van Marter LJ, Allred EN, Pagano M, et al. and Neonatal Committees for the Developmental Epidemiology Network: Do clinical markers of barotraumas and oxygen toxicity explain interhospital variation in rates of chronic lung disease? Pediatrics 2000, 105:1194-1201.
9. Jobe AH, Ikegami M: Prevention of bronchopulmonary dysplasia. Curr Opin Pediatr 2001, 13:124-129.
10. Spahr RC, Klein AM, Brown DR, et al.: Fluid administration and bronchopulmonary dysplasia. Am J Dis Child 1980, 134:958-960.
11. Spitzer AR, Fox WW, Delivoria-Papadopoulos M: Maximum diuresis-a factor in predicting recovery from respiratory distress syndrome and the development of bronchopulmonary dysplasia. J Pediatr 1981, 98:476-479.
12. Van Marter LJ, Leviton A, Allred EN, et al.: Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J Pediatr 1990, 116:942-949.
13. Stevenson JG: Fluid administration in the association of patent ductus arteriosus complicating respiratory distress syndrome. J Pediatr 1977, 90:257-261.
14. Bell EF, Acarregui MJ: Restricted versus liberal fluid intake for preventing morbidity and mortality in preterm infants Cochrane Review). In The Cochrane Library, Issue 4. Chichester, UK: John Wiley & Sons; 2003.
15. Fowley FW, Davis PG: Prophylactic intravenous indomethacin for preventing mortality and morbidity in premature infants. (Cochrane Review). In: The Cochrane Library, Issue 4, 2003. Chichester, UK: John Riley & Sons, LTD.
16. Cooke L, Steer P, Woodgate P: Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. (Cochrane Review). In: The Cochrane library, Issue 4, 2003. Chichester, UK: John Riley & Sons, LTD
17. Lorenz JM, Kleinman LI, Kotagal UR, Reller MD: Water balance in very low-birth-weight infants: relationship to water and sodium intake and effect on outcome. J Pediatr 1982, 101:423-432.
18. Costarino AT, Gruskay JA, Corcoran L, et al.: Sodium restriction versus daily maintenance replacement in very low birth weight premature neonates: a randomized, blind therapeutic trial. J Pediatr 1992, 120:99-106.
19. Bell EF, Warburton D, Stonestreet BS, et al.: Effect of fluid administration on symptomatic patent ductus arteriosus and congestive heart failure in premature infants. N Engl J Med 1980, 302:598-604.
20. Northway WH, Rosan RC, Porter DY: Pulmonary disease following respirator therapy of hyaline-membrane disease. N Engl J Med 1967, 276:357-358.
21. Tammela OKT, Koivisto ME: Fluid restriction fro preventing bronchopulmonary dysplasia? Reduced fluid intake during the first weeks of life improves the outcome of low-birth-weight infants. Acta Paediatr 1992, 81:207-212.
22. Hartnoll G, Betremieux P, Modi N: Randomised controlled trial of postnatal sodium supplementation on oxygen dependency and body weight in 25-30 week gestational age infants. Arch Dis Child Fetal Neonatal Ed 2000, 82:F19-F23.
23. Hartnoll G, Betremieuz P, Modi N: Randomised controlled trial of postnatal sodium supplementation on body composition in 25 to 30 week gestational age infants. Arch Dis Child Fetal Neonatal Ed 2000, 82:F24-F28.
24. Ekblad H, Kero P, Shaffer SG, et al.: Extracellular volume in preterm infants: influence of gestational age and colloids. Early Hum Dev 1991, 27:1-7.
25. So KW, Fok TF, Ng PC, et al.: Randomised controlled trial of colloid or crystalloid in hypotensive infants. Arch Dis Child Fetal Neonatal Ed 1997, 76:F43-F46.
26. Lorenz JM: Fetal and neonatal body fluid compartments with reference to growth and development. In Fetal and Neonatal Physiology, 3rd ed. Edited by Polin RA, Fox WW, Abman S. Philadelphia: WB Saunders; 2003.